2023 MATCH DAY

On Friday, March 17, at LSU Health Shreveport’s annual Match Day celebration, 140 fourth-year medical students learned which institutions they matched to and where they will complete the next three to seven years of their medical education. The day was filled with emotion as students reflected on their accomplishments leading up to this career-defining moment, surrounded by family and friends.

LSU Health Shreveport is proud to remain highly competitive in the 2023 Main Residency Match® with a match rate of 98.6%. Of the 2023 class, 29.3% will be staying at LSU Health Shreveport for their residency and 45.7% of the graduates will be staying in Louisiana, which is critical with Louisiana facing a shortfall in the number of physicians needed to meet the healthcare demands of the state. Of those remaining, LSU Health Shreveport medical students matched to highly competitive residencies outside of the state and will train at prestigious programs around the country including Weill Cornell, University of AlabamaBirmingham (UAB), Emory, George Washington University, Baylor, University of Michigan and several others.

Match Day also reveals the number of newly minted physicians coming into the Shreveport-Bossier area to begin their post graduate training. LSU Health Shreveport School of Medicine successfully filled 193 residency and fellowship positions. The new group of trainees will be welcomed to Shreveport in July, where they will train at Ochsner LSU Health Shreveport Academic Medical Center, St. Mary Medical Center and Monroe Medical Center along with other partner hospitals.

David Fajgenbaum, MD, MBA, MSc, is a physician-scientist at the University of Pennsylvania, Co-Founder & President of the Castleman Disease Collaborative Network (CDCN), and national bestselling author of Chasing My Cure: A Doctor’s Race to Turn Hope Into Action. He went from being a beast-like college quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, Dr. Fajgenbaum spearheaded an innovative approach to research through the CDCN and discovered a treatment that is saving his life and others. Since then, he has also identified and advanced eleven other treatments for autoimmunity and cancer. He recently co-founded Every Cure, a non-profit on a mission to unlock the full potential of FDAapproved medicines to treat every disease possible. He has been profiled by The NY Times, TODAY, GMA, and others and received numerous awards including the 2016 Atlas Award along with then VP Joe Biden and Forbes 30 Under 30. Dr. Fajgenbaum earned a BS from Georgetown University, MSc from the University of Oxford, MD from the University of Pennsylvania, and MBA from The Wharton School.